Differentiation of human pluripotent stem cells to brain microvascular endothelial cell-like cells suitable to study immune cell interactions
DOI: 10.1016/j.xpro.2021.100563
Authors: Hideaki Nishihara; Benjamin D. Gastfriend; Pelin Kasap; Sean P. Palecek; Eric V. Shusta; Britta Engelhardt
Step 1: iPSC/ESC maintainance
day 0 ~ 1
culture “adherent” human PSC in “mTeSR” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| FGF | — | — |
| Y27632 | 1.0e-5 | mol/l |
| Versene | — | — |
| Accutase | — | — |
Step 2: mesoderm 1
day 1 ~ 2
culture “adherent” human PSC in “LaSR basal medium” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| CHIR90021 | 8.0e-6 | mol/l |
Step 3: mesoderm 2
day 2 ~ 3
culture “adherent” human PSC in “LaSR basal medium” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should be changed once in “1” days.
Ideally, “EPC” should express “PECAM1” at the end of culture.
Step 4: endothelial 1
day 3 ~ 6
culture “adherent” human EPC in “Human Endothelial SFM” for “3” days. For ECM, use “Collagen IV” at “0.01” “g/l”. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| Y27632 | 5.0e-6 | mol/l |
| B-27 Supplement | 1 | x |
| FGF | 2.0e-5 | g/l |
| VEGF | 1.0e-5 | g/l |